- Email: [email protected]
Continuing Medical Education
A12
I. J. Radiation Oncology d Biology d Physics
Volume 72, Number 1, Supplement, 2008
CONTINUING MEDICAL EDUCATION PHYSICIANS The American Society for Therapeutic Radiology and Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. ASTRO designates this educational activity for a maximum of 40.5 AMA PRA Category 1 CreditsÔ. Physicians should only claim credit commensurate with the extent of their participation in the activity. PHYSICISTS Application has been submitted to the Commission on Accreditation of Medical Physics Education Program for CAMPEP credit. TECHNOLOGISTS Application has been submitted to the American Society for Radiologic Technologists for designation of Category A continuing education credit. DOSIMETRISTS Application has been submitted to the Medical Dosimetrist Certification Board for designation of MDCB credit. NURSES The Oncology Nursing Society (ONS) is accredited as an approver of continuing education for nurses by the American Nurses Credentialing Center’s Commission on Accreditation. Application has been submitted to ONS for designation of CEU credit. DISCLOSURE OF VESTED INTEREST Presenters have been asked to disclose the existence of any financial or other relationship they have with the manufacturer(s) or any commercial product(s) or provider(s) of any commercial services discussed in the presentation. This disclosure information is noted at the end of each abstract. Presenters should also announce their disclosure information to the audience at the beginning of their presentation and in accordance with ACCME standards. OFF-LABEL USE ASTRO’s scientific program may include presentations on drugs or devices, or uses of drugs or devices, which may not have been approved by the FDA or have been approved by the FDA for specific uses only. The FDA has stated that it is the responsibility of the physician to determine the FDA clearance status of each drug or device he or she wishes to use in clinical practice. Please refer to the official prescribing information for approved indications, contraindications and warnings. DISCLAIMER ASTRO is committed to the free exchange of medical education. Inclusion of any presentation in this program, including presentations of off-label uses, does not imply an endorsement by ASTRO of the uses, products or techniques presented.
Information included in this publication is current as of May 30, 2008 and is subject to change.
I. J. Radiation Oncology d Biology d Physics
Volume 72, Number 1, Supplement, 2008
CONTINUING MEDICAL EDUCATION PHYSICIANS The American Society for Therapeutic Radiology and Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. ASTRO designates this educational activity for a maximum of 40.5 AMA PRA Category 1 CreditsÔ. Physicians should only claim credit commensurate with the extent of their participation in the activity. PHYSICISTS Application has been submitted to the Commission on Accreditation of Medical Physics Education Program for CAMPEP credit. TECHNOLOGISTS Application has been submitted to the American Society for Radiologic Technologists for designation of Category A continuing education credit. DOSIMETRISTS Application has been submitted to the Medical Dosimetrist Certification Board for designation of MDCB credit. NURSES The Oncology Nursing Society (ONS) is accredited as an approver of continuing education for nurses by the American Nurses Credentialing Center’s Commission on Accreditation. Application has been submitted to ONS for designation of CEU credit. DISCLOSURE OF VESTED INTEREST Presenters have been asked to disclose the existence of any financial or other relationship they have with the manufacturer(s) or any commercial product(s) or provider(s) of any commercial services discussed in the presentation. This disclosure information is noted at the end of each abstract. Presenters should also announce their disclosure information to the audience at the beginning of their presentation and in accordance with ACCME standards. OFF-LABEL USE ASTRO’s scientific program may include presentations on drugs or devices, or uses of drugs or devices, which may not have been approved by the FDA or have been approved by the FDA for specific uses only. The FDA has stated that it is the responsibility of the physician to determine the FDA clearance status of each drug or device he or she wishes to use in clinical practice. Please refer to the official prescribing information for approved indications, contraindications and warnings. DISCLAIMER ASTRO is committed to the free exchange of medical education. Inclusion of any presentation in this program, including presentations of off-label uses, does not imply an endorsement by ASTRO of the uses, products or techniques presented.
Information included in this publication is current as of May 30, 2008 and is subject to change.